The Federal Workforce Reproductive Rights Protection Act prevents federal agencies from relocating headquarters or major operations to states with laws restricting or banning abortion, while also barring the use of funds to build or lease facilities in those locations. To support federal employees who need to access reproductive health care, the bill allows workers to decline transfers to restrictive states, grants up to 21 days of paid leave for travel to obtain such services, and provides reimbursement for travel costs without requiring disclosure of the specific medical procedure. Additionally, the legislation prohibits government agencies from investigating an employee's use of abortion services when reviewing security clearances or making personnel decisions and protects workers from retaliation if they exercise these new rights.
This Senate resolution commemorates the fourth anniversary of the 2022 Supreme Court decision in Dobbs v. Jackson Women's Health Organization, which overturned the previous federal right to abortion. The document expresses the Senate's support for state authority to regulate abortion and acknowledges the work of pregnancy centers that assist expectant mothers. It formally declares the Senate's commitment to protecting unborn life and supporting families, while noting the ongoing policy challenges related to abortion access. As a symbolic measure, the bill does not create new laws or alter existing regulations but serves to record the Senate's stance on the issue.
The Saving FACE Act of 2026 amends federal criminal law to remove penalties for obstructing access to abortion services. It achieves this by changing the name of the relevant statute from "Freedom of Access to Clinics" to "Freedom of Access to Church" and removing the specific definition of abortion from the list of protected activities. Additionally, the bill updates the legal definition of abortion to exclude the intentional termination of a pregnancy, thereby narrowing the scope of the obstruction statute. These changes directly affect individuals who might otherwise face criminal charges for blocking entry to facilities providing abortion care.
This bill restricts how nonmilitary foreign assistance funds can be used by prohibiting organizations from supporting abortion, gender ideology, or discriminatory equity ideology outside the United States. It requires recipients of these funds to agree not to provide or promote these specific activities, mandates that U.S. organizations keep their foreign aid programs physically and financially separate from such work, and allows the Secretary of State to require foreign governments to place funds in segregated accounts to prevent misuse. The legislation defines prohibited concepts narrowly, such as defining sex strictly by biological classification and limiting exceptions for abortion to cases where a woman's life is in immediate danger. While the rules apply to foreign and international organizations receiving U.S. aid, U.S.-based nonprofits are exempt from the ban on providing these services domestically but must still ensure their foreign-funded projects do not engage in them.
This resolution expresses the House of Representatives' view that monitoring water systems for medication abortion drugs should not be used to track or restrict access to abortion care. It states that such surveillance lacks scientific support and misuses environmental laws to target reproductive health services. The bill asserts that medications like mifepristone are safe and effective, and that water protection efforts should focus on actual environmental threats rather than political agendas. As a non-binding statement of sentiment, it does not create new laws but aims to influence future policy discussions on reproductive rights and environmental regulation.
This bill directs the Secretary of Health and Human Services to require public institutions of higher education receiving Medical Student Education grants to include menopause training in their medical school curricula. The key provision makes this specific training a mandatory condition for receiving federal funding, aiming to better prepare physicians across all specialties to care for patients experiencing menopause. By tying the requirement directly to grant eligibility, the legislation ensures that public medical schools must integrate this topic into their existing programs.
The Maternal Health for Veterans Act establishes a new program within the Department of Veterans Affairs to coordinate maternity care for enrolled veterans from the start of pregnancy through 12 months after birth. This initiative requires the VA to systematically track mental health screenings, implement performance goals to improve care quality, and provide specialized training to community providers regarding the unique needs of veterans with service-related mental or behavioral health conditions. Additionally, the bill mandates annual reports detailing maternal health outcomes, such as mortality and severe morbidity, broken down by demographics like race, disability status, and rural residence to address specific disparities. The legislation also updates legal definitions for terms like "maternal mortality" and repeals a previous section of the Protecting Moms Who Served Act to align with these new requirements.
The Pregnancy Loss Mental Health Research Act of 2026 directs the National Institutes of Health to expand research on mental health issues following pregnancy loss, including miscarriage, stillbirth, and abortion. This legislation authorizes $4.5 million for fiscal years 2027 and 2028 to fund studies on the causes, diagnosis, and treatment of these conditions, as well as a long-term national study to track their prevalence and duration. Additionally, the bill modifies existing public health grants to allow funding for mental health services specifically for individuals who have experienced pregnancy loss, while prohibiting the use of these funds by entities that perform abortions except in cases of rape, incest, or life-threatening medical emergencies.
The Reproductive Health Care Accessibility Act aims to improve access to reproductive health services for individuals with disabilities by addressing barriers such as inaccessible facilities and a lack of provider training. The bill authorizes funding for several programs designed to train healthcare professionals on disability-inclusive care and to expand the workforce of doctors, nurses, and students with disabilities in reproductive health fields. Additionally, it establishes a National Technical Assistance Center to offer resources and best practices to healthcare providers and communities, while also funding research to better understand and eliminate systemic obstacles to care. These measures collectively seek to ensure that people with disabilities receive equitable, culturally competent, and accessible reproductive health services.
The Hormone Health Data and Research Act directs the National Institutes of Health and the U.S. Preventive Services Task Force to study hormone levels in women before they enter perimenopause. Specifically, the bill requires an evaluation of existing evidence regarding how much these hormone levels vary and whether testing them early helps doctors diagnose or manage perimenopause. Within 18 months of passing, these agencies must submit a report to Congress summarizing their findings and suggesting areas for future research. This legislation primarily affects women experiencing perimenopause and the medical professionals who treat them by mandating a review of current scientific data.
